Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

January 16, 2022
Preprint
Open Access

NF-κB memory coordinates transcriptional responses to dynamic inflammatory stimuli

BioRxiv : the Preprint Server for Biology
A. G. WangSavas Tay
January 16, 2022

Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs.

Archives of Toxicology
Noa Madar-BalakirskiHadar Marcus
January 16, 2022

Stiffness heterogeneity of small viral capsids.

Physical Review. E
Lucas MenouMartin Castelnovo
January 15, 2022
Preprint
Open Access

Cross-species permissivity: structure of a goat adeno-associated virus and its complex with the human receptor, AAVR

BioRxiv : the Preprint Server for Biology
E. E. LargeM. S. Chapman
January 15, 2022
Comment / Editorial

Safety of Adeno-associated virus-based vector-mediated gene therapy-impact of vector dose.

Cancer Gene Therapy
Shubham MauryaGiridhara R Jayandharan
January 15, 2022
Open Access

A Single-Cell Transcriptome Profiling of Anterior Kidney Leukocytes From Nile Tilapia (Oreochromis niloticus).

Frontiers in Immunology
Liting WuJianmin Ye
January 14, 2022

A small stem-loop-forming region within the 3'-UTR of a non-polyadenylated LCMV mRNA promotes translation.

The Journal of Biological Chemistry
Mei HashizumeMasaharu Iwasaki
January 14, 2022
Review

Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges.

Journal of Controlled Release : Official Journal of the Controlled Release Society
Eman A TahaAkitsu Hotta
January 13, 2022
Preprint
Open Access

AAV11 permits efficient retrograde targeting of projection neurons

BioRxiv : the Preprint Server for Biology
Kunz HanF. Xu
January 14, 2022

Prevalence of CYLD mutations in Vietnamese patients with polycythemia vera.

Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University
Do Thi TrangNguyen Thi Xuan
January 14, 2022

VikAD, a Vika site-specific recombinase-based system for efficient and scalable helper-dependent adenovirus production.

Molecular Therapy. Methods & Clinical Development
Stacia PhillipsSamuel M Young
January 14, 2022

Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy.

Brain : a Journal of Neurology
Yu Young JeongQian Cai
January 14, 2022
Open Access

A deep generative model for multi-view profiling of single-cell RNA-seq and ATAC-seq data.

Genome Biology
Gaoyang LiQi Liu

Sign up to follow this feed and discover related papers.

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

© 2022 Meta ULC. All rights reserved
/feed-previews/cell-type-specific-viral-vectors/cff1d574-b9e6-4b8b-90f3-057421134853